Below are the financial statements of Madrigal Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in thousands of USD | 2024 |
|---|---|
| Current assets | — |
| Cash and cash equivalents | 100,019a |
| Restricted cash | 5,000a |
| Marketable securities | 826,232a |
| Trade receivables, net | 53,822a |
| Inventory | 34,068a |
| Prepaid expenses and other current assets | 13,786a |
| Total current assets | 1,032,927a |
| Assets | — |
| Property and equipment, net | 2,190a |
| Intangible assets, net | 4,729a |
| Right-of-use asset | 2,401a |
| Total assets | 1,042,247a |
| Current liabilities | — |
| Accounts payable | 43,599a |
| Accrued liabilities | 124,695a |
| Lease liability | 983a |
| Total current liabilities | 169,277a |
| Long term liabilities | — |
| Loan payable, net of discount | 117,569a |
| Lease liability | 1,018a |
| Total long term liabilities | 118,587a |
| Total liabilities | 287,864a |
| Stockholders’ equity | — |
| Preferred stock | 0a |
| Common stock | 2a |
| Additional paid-in-capital | 2,556,095a |
| Accumulated other comprehensive income | 468a |
| Accumulated deficit | -1,802,182a |
| Total stockholders’ equity | 754,383a |
| Total liabilities and stockholders’ equity | 1,042,247a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Madrigal Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.